Inactive Instrument

SANUWAVE Health, Inc. Stock OTC Bulletin Board

Equities

Medical Equipment, Supplies & Distribution

Sales 2022 16.74M Sales 2023 20.4M Capitalization 14.83M
Net income 2022 -10M Net income 2023 -25M EV / Sales 2022 3.13 x
Net Debt 2022 39.95M Net Debt 2023 30.15M EV / Sales 2023 2.2 x
P/E ratio 2022
-1.14 x
P/E ratio 2023
-0.4 x
Employees -
Yield 2022 *
-
Yield 2023
-
Free-Float 0%
More Fundamentals * Assessed data
Dynamic Chart
Managers TitleAgeSince
Chief Executive Officer 51 22-08-04
President 39 23-07-30
Chief Operating Officer 63 06-02-28
Members of the board TitleAgeSince
Director/Board Member 54 05-07-31
Chief Executive Officer 51 22-08-04
Director/Board Member 52 16-04-17
More insiders
Sanuwave Health, Inc. is an ultrasound and shock wave technology company. The Company is a provider of Food and Drug Administration (FDA)-approved wound care products. It is focused on the research, development, and commercialization of its patented, non-invasive and biological response-activating medical systems for the repair and regeneration of skin, musculoskeletal tissue, and vascular structures. The Company applies and researches its patented energy transfer technologies in wound healing, orthopedic/spine, aesthetic/cosmetic, and others. Its two primary systems are UltraMIST and PACE. The UltraMIST system provides, through a fluid mist, low-frequency, non-contact, and pain free ultrasound energy deep inside the wound bed that promotes healing from within. The PACE systems use acoustic pressure shockwaves generated by the Company's Pulsed Acoustic Cellular Expression (PACE) technology to converge at precise selected targets to produce an extremely short duration compression burst.
More about the company